Hong Kong Med J 2007;13(Suppl 2):S37-9
Effect of co-treatment with diltiazem on ciclosporin dosage in renal transplant patients
CR Kumana, TM Chan, KL Tong, CS Li, IJ Lauder, T Walley
Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong
1. We have demonstrated the costeffectiveness of using diltiazem co-treatment with ciclosporin in the management of renal transplant patients.
2. We observed no excess of serious adverse outcomes or complications (deaths, rejection episodes, infections, renal functional impairment, hospital inpatient days and hospital outpatient visits) in patients receiving diltiazem.
2. We observed no excess of serious adverse outcomes or complications (deaths, rejection episodes, infections, renal functional impairment, hospital inpatient days and hospital outpatient visits) in patients receiving diltiazem.